Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy - ICD-10-CM Quality Payment Program Measure
| Quality Measure | Description | High Priority | Submission Methods |
|---|---|---|---|
| Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy | Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT. | NO | Electronichealthrecord |
Linked ICD-10 Codes
The following ICD-10-CM codes are linked to the quality measure bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).
| ICD Code | Description | Category |
|---|